449 related articles for article (PubMed ID: 31708928)
1. Selective Histone Deacetylase 6 Inhibition Normalizes B Cell Activation and Germinal Center Formation in a Model of Systemic Lupus Erythematosus.
Ren J; Catalina MD; Eden K; Liao X; Read KA; Luo X; McMillan RP; Hulver MW; Jarpe M; Bachali P; Grammer AC; Lipsky PE; Reilly CM
Front Immunol; 2019; 10():2512. PubMed ID: 31708928
[TBL] [Abstract][Full Text] [Related]
2. Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.
Ren J; Liao X; Vieson MD; Chen M; Scott R; Kazmierczak J; Luo XM; Reilly CM
Clin Exp Immunol; 2018 Jan; 191(1):19-31. PubMed ID: 28876451
[TBL] [Abstract][Full Text] [Related]
3. Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB/W mice.
Regna NL; Vieson MD; Luo XM; Chafin CB; Puthiyaveetil AG; Hammond SE; Caudell DL; Jarpe MB; Reilly CM
Clin Immunol; 2016 Jan; 162():58-73. PubMed ID: 26604012
[TBL] [Abstract][Full Text] [Related]
4. CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus.
Choi EW; Song JW; Ha N; Choi YI; Kim S
Sci Rep; 2018 Nov; 8(1):17297. PubMed ID: 30470828
[TBL] [Abstract][Full Text] [Related]
5. HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.
Maharaj K; Powers JJ; Mediavilla-Varela M; Achille A; Gamal W; Quayle S; Jones SS; Sahakian E; Pinilla-Ibarz J
Front Immunol; 2020; 11():590072. PubMed ID: 33329575
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Lupus B Cell Biology: PI3K, IFNγ, and Chromatin.
Bacalao MA; Satterthwaite AB
Front Immunol; 2020; 11():615673. PubMed ID: 33519824
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production.
Zhang M; Yao C; Cai J; Liu S; Liu XN; Chen Y; Wang S; Ji P; Pan M; Kang Z; Wang Y
J Transl Med; 2019 Jan; 17(1):37. PubMed ID: 30670047
[TBL] [Abstract][Full Text] [Related]
8. HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.
Laino AS; Betts BC; Veerapathran A; Dolgalev I; Sarnaik A; Quayle SN; Jones SS; Weber JS; Woods DM
J Immunother Cancer; 2019 Feb; 7(1):33. PubMed ID: 30728070
[TBL] [Abstract][Full Text] [Related]
9. Thymic B Cells Promote Germinal Center-Like Structures and the Expansion of Follicular Helper T Cells in Lupus-Prone Mice.
Hidalgo Y; Núñez S; Fuenzalida MJ; Flores-Santibáñez F; Sáez PJ; Dorner J; Lennon-Dumenil AM; Martínez V; Zorn E; Rosemblatt M; Sauma D; Bono MR
Front Immunol; 2020; 11():696. PubMed ID: 32411134
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of BTK prevents murine lupus and antibody-mediated glomerulonephritis.
Rankin AL; Seth N; Keegan S; Andreyeva T; Cook TA; Edmonds J; Mathialagan N; Benson MJ; Syed J; Zhan Y; Benoit SE; Miyashiro JS; Wood N; Mohan S; Peeva E; Ramaiah SK; Messing D; Homer BL; Dunussi-Joannopoulos K; Nickerson-Nutter CL; Schnute ME; Douhan J
J Immunol; 2013 Nov; 191(9):4540-50. PubMed ID: 24068666
[TBL] [Abstract][Full Text] [Related]
11. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
[TBL] [Abstract][Full Text] [Related]
12. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
Xiang L; Liu A; Xu G
Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615
[TBL] [Abstract][Full Text] [Related]
13. HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus.
Kim YY; Park KT; Jang SY; Lee KH; Byun JY; Suh KH; Lee YM; Kim YH; Hwang KW
Arthritis Res Ther; 2017 Sep; 19(1):211. PubMed ID: 28950886
[TBL] [Abstract][Full Text] [Related]
14. STAT3 Signaling in B Cells Is Critical for Germinal Center Maintenance and Contributes to the Pathogenesis of Murine Models of Lupus.
Ding C; Chen X; Dascani P; Hu X; Bolli R; Zhang HG; Mcleish KR; Yan J
J Immunol; 2016 Jun; 196(11):4477-86. PubMed ID: 27183592
[TBL] [Abstract][Full Text] [Related]
15. Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus.
Malkiel S; Barlev AN; Atisha-Fregoso Y; Suurmond J; Diamond B
Front Immunol; 2018; 9():427. PubMed ID: 29556239
[TBL] [Abstract][Full Text] [Related]
16. ACY 1215, a histone deacetylase 6 inhibitor, inhibits cancer cell growth in melanoma.
Wang F; Zhong BW; Zhao ZR
J Biol Regul Homeost Agents; 2018; 32(4):851-858. PubMed ID: 30043566
[TBL] [Abstract][Full Text] [Related]
17. Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma.
Liu Z; Cai Y; Yang Y; Li A; Bi R; Wang L; Shen X; Wang W; Jia Y; Yu B; Cao B; Cui W; Wei P; Zhou X
J Pathol; 2018 Oct; 246(2):141-153. PubMed ID: 29876933
[TBL] [Abstract][Full Text] [Related]
18. Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche.
Wang W; Rangel-Moreno J; Owen T; Barnard J; Nevarez S; Ichikawa HT; Anolik JH
J Immunol; 2014 Apr; 192(7):3011-20. PubMed ID: 24574498
[TBL] [Abstract][Full Text] [Related]
19. HDAC expression and activity is upregulated in diseased lupus-prone mice.
Regna NL; Vieson MD; Gojmerac AM; Luo XM; Caudell DL; Reilly CM
Int Immunopharmacol; 2015 Dec; 29(2):494-503. PubMed ID: 26471208
[TBL] [Abstract][Full Text] [Related]
20. Arctigenin inhibits abnormal germinal center reactions and attenuates murine lupus by inhibiting IFN-I pathway.
Zhang X; Zou M; Liang Y; Yang Y; Jing L; Sun M; Dong Z; Zhang X; Xiong H; Dong G
Eur J Pharmacol; 2022 Mar; 919():174808. PubMed ID: 35151645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
